RxNorm Semantic Concepts Index - 271
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "271".
RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
---|---|---|---|---|
RxCUI: 271 | Actin | Designated preferred name (PT) | NO | |
RxCUI: 271 | Actin | Full form of descriptor (FN) | NO | |
RxCUI: 2710 | Polymyxin E sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2710 | Polymyxin E sulfate | Designated preferred name (PT) | YES | |
RxCUI: 2710 | Polymyxin E sulfate | Full form of descriptor (FN) | YES | |
RxCUI: 2710 | Polymyxin E sulfate | British synonym (SYGB) | British synonym of another TTY, given for clarity. | YES |
RxCUI: 2710 | Polymyxin E sulfate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2710 | Polymyxin E sulfate | British synonym (SYGB) | British synonym of another TTY, given for clarity. | YES |
RxCUI: 27100 | Homoharringtonine | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 27100 | Homoharringtonine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 27100 | Homoharringtonine | Designated preferred name (PT) | YES | |
RxCUI: 27100 | Homoharringtonine | Full form of descriptor (FN) | YES | |
RxCUI: 27104 | Homoisocitrate dehydrogenase | Designated preferred name (PT) | NO | |
RxCUI: 27104 | Homoisocitrate dehydrogenase | Full form of descriptor (FN) | NO | |
RxCUI: 2710417 | Ctexli | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2710418 | chenodeoxycholate 250 MG [Ctexli] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2710419 | Ctexli Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2710420 | Ctexli Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2710421 | chenodeoxycholate Oral Tablet [Ctexli] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2710422 | Ctexli 250 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2710422 | Ctexli 250 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2710422 | Ctexli 250 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2710423 | darunavir 675 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2710424 | darunavir 675 MG / cobicistat 150 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2710424 | darunavir 675 MG / cobicistat 150 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2710424 | darunavir 675 MG / cobicistat 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2710425 | cobicistat 150 MG / darunavir 675 MG [Prezcobix] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2710426 | PREZCOBIX 675 MG / 150 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2710426 | PREZCOBIX 675 MG / 150 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2710426 | PREZCOBIX 675 MG / 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2710427 | bisacodyl Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2710428 | bisacodyl 5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2710428 | bisacodyl 5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2710429 | zolbetuximab-clzb 300 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2710430 | zolbetuximab-clzb 300 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2710430 | zolbetuximab-clzb 300 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2710431 | zolbetuximab-clzb 300 MG [Vyloy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2710432 | VYLOY 300 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2710432 | VYLOY 300 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2710432 | VYLOY 300 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2710434 | berdazimer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2710435 | berdazimer 0.103 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2710436 | berdazimer Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2710437 | berdazimer Topical Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2710438 | berdazimer 10.3 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2710438 | berdazimer 10.3 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2710438 | berdazimer 10.3 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2710443 | Zelsuvmi 10.3 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2710443 | Zelsuvmi 10.3 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2710443 | Zelsuvmi 10.3 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2710443 | Zelsuvmi 10.3 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2710444 | berdazimer free acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2710445 | berdazimer sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2710448 | atrasentan hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2710449 | atrasentan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2710450 | atrasentan 0.75 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2710451 | atrasentan Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2710452 | atrasentan Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2710453 | atrasentan Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2710454 | atrasentan 0.75 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2710454 | atrasentan 0.75 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2710454 | atrasentan 0.75 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2710455 | Vanrafia | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2710456 | atrasentan 0.75 MG [Vanrafia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2710457 | Vanrafia Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2710458 | Vanrafia Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2710459 | atrasentan Oral Tablet [Vanrafia] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2710460 | VANRAFIA 0.75 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2710460 | VANRAFIA 0.75 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2710460 | VANRAFIA 0.75 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2710465 | Prunus lannesiana flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2710482 | meloxicam / rizatriptan | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
RxCUI: 2710538 | ethanol 50 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2710538 | ethanol 50 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2710538 | ethanol 50 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2710538 | ethanol 50 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2710539 | ethanol 91 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2710539 | ethanol 91 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2710539 | ethanol 91 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2710539 | ethanol 91 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2710757 | Dolasetron mesylate 20 mg powder for solution for injection ampule | British preferred term (PTGB) | NO | |
RxCUI: 2710757 | Dolasetron mesylate 20 mg powder for solution for injection ampule | Designated preferred name (PT) | NO | |
RxCUI: 2710757 | Dolasetron mesylate 20 mg powder for solution for injection ampule | Full form of descriptor (FN) | NO | |
RxCUI: 2710834 | mineral oil 0.3 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2710835 | colloidal oatmeal / mineral oil Topical Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2710836 | colloidal oatmeal 2 % / mineral oil 30 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2710836 | colloidal oatmeal 2 % / mineral oil 30 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2710836 | colloidal oatmeal 2 % / mineral oil 30 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 27109 | Homoserine acetyltransferase | Designated preferred name (PT) | NO | |
RxCUI: 27109 | Homoserine acetyltransferase | Full form of descriptor (FN) | NO | |
RxCUI: 27110 | Homoserine kinase | Designated preferred name (PT) | NO | |
RxCUI: 27110 | Homoserine kinase | Full form of descriptor (FN) | NO | |
RxCUI: 27111 | Homoserine o-transsuccinylase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 27111 | Homoserine o-transsuccinylase | Designated preferred name (PT) | NO | |
RxCUI: 27111 | Homoserine o-transsuccinylase | Full form of descriptor (FN) | NO | |
RxCUI: 2711361 | Vernonia appendiculata whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2711362 | Pleione yunnanensis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2711539 | Streptococcus oralis | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2711541 | magnesium glycinate 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2711541 | magnesium glycinate 100 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2711542 | diazoxide choline | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2711543 | diazoxide choline 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2711544 | diazoxide Extended Release Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2711548 | diazoxide choline 150 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2711548 | diazoxide choline 150 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2711548 | diazoxide choline 150 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2711549 | diazoxide choline 150 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2711549 | diazoxide choline 150 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2711550 | Vykat | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2711551 | diazoxide choline 150 MG [Vykat] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2711552 | Vykat Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2711553 | Vykat Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2711554 | diazoxide Extended Release Oral Tablet [Vykat] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2711556 | vykat XR 150 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2711556 | vykat XR 150 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2711556 | vykat XR 150 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2711557 | vykat XR 150 MG Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2711557 | vykat XR 150 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2711557 | vykat XR 150 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2711558 | diazoxide choline 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2711559 | diazoxide choline 25 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2711559 | diazoxide choline 25 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2711559 | diazoxide choline 25 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2711560 | diazoxide choline 25 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2711560 | diazoxide choline 25 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2711561 | diazoxide choline 25 MG [Vykat] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2711562 | vykat XR 25 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2711562 | vykat XR 25 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2711562 | vykat XR 25 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2711563 | vykat XR 25 MG Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2711563 | vykat XR 25 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2711563 | vykat XR 25 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2711564 | diazoxide choline 75 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2711565 | diazoxide choline 75 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2711565 | diazoxide choline 75 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2711565 | diazoxide choline 75 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2711566 | diazoxide choline 75 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2711566 | diazoxide choline 75 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2711567 | diazoxide choline 75 MG [Vykat] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2711568 | vykat XR 75 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2711568 | vykat XR 75 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2711568 | vykat XR 75 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2711569 | vykat XR 75 MG Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2711569 | vykat XR 75 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2711569 | vykat XR 75 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2711570 | cyanocobalamin 400 MCG / folic acid 1000 MCG / pyridoxine HCl 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2711570 | cyanocobalamin 400 MCG / folic acid 1000 MCG / pyridoxine HCl 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2711570 | cyanocobalamin 400 MCG / folic acid 1000 MCG / pyridoxine HCl 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2711574 | Product containing precisely sodium fluoride 500 microgram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
RxCUI: 2711574 | Product containing precisely sodium fluoride 500 microgram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
RxCUI: 2711637 | guselkumab Induction Pack for Crohn's Disease (2 count) | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
RxCUI: 2711637 | guselkumab Induction Pack for Crohn's Disease (2 count) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2711637 | guselkumab Induction Pack for Crohn's Disease (2 count) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2711638 | Tremfya Induction Pack for Crohn's Disease | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 2711638 | Tremfya Induction Pack for Crohn's Disease | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2711638 | Tremfya Induction Pack for Crohn's Disease | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2711687 | allantoin 0.0075 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2711688 | allantoin 0.75 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2711688 | allantoin 0.75 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2711688 | allantoin 0.75 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2711691 | Fibraurea tinctoria whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2711692 | Piper sarmentosum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2711693 | isotretinoin 30 MG [Amnesteem] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2711693 | isotretinoin 30 MG [Amnesteem] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2711694 | Amnesteem 30 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2711694 | Amnesteem 30 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2711694 | Amnesteem 30 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2711694 | Amnesteem 30 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2711696 | tenecteplase 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2711697 | tenecteplase 25 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2711697 | tenecteplase 25 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2711698 | tenecteplase 25 MG [Tnkase] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2711699 | TNKase 25 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2711699 | TNKase 25 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2711699 | TNKase 25 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2711700 | thyroid (USP) 16.25 MG [Adthyza] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2711701 | ADTHYZA 16.25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2711701 | ADTHYZA 16.25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2711701 | ADTHYZA 16.25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2711702 | thyroid (USP) 65 MG [Adthyza] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2711703 | ADTHYZA 65 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2711703 | ADTHYZA 65 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2711703 | ADTHYZA 65 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2711704 | thyroid (USP) 97.5 MG [Adthyza] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2711705 | ADTHYZA 97.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2711705 | ADTHYZA 97.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2711705 | ADTHYZA 97.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2711706 | thyroid (USP) 130 MG [Adthyza] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2711707 | ADTHYZA 130 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2711707 | ADTHYZA 130 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2711707 | ADTHYZA 130 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2711708 | thyroid (USP) 32.5 MG [Adthyza] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2711709 | ADTHYZA 32.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2711709 | ADTHYZA 32.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2711709 | ADTHYZA 32.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2711711 | tripelennamine hydrochloride 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2711712 | tripelennamine HCl 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2711712 | tripelennamine HCl 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2711712 | tripelennamine HCl 1 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2711783 | Erysimum cheiri seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2711784 | Leptinotarsa decemlineata preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2711785 | meloxicam 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2711786 | meloxicam / rizatriptan Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2711787 | meloxicam / rizatriptan Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2711788 | meloxicam / rizatriptan Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2711789 | meloxicam 20 MG / rizatriptan 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2711789 | meloxicam 20 MG / rizatriptan 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2711789 | meloxicam 20 MG / rizatriptan 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2711790 | Symbravo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2711791 | meloxicam 20 MG / rizatriptan 10 MG [Symbravo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2711792 | Symbravo Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2711793 | Symbravo Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2711794 | meloxicam / rizatriptan Oral Tablet [Symbravo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2711795 | SYMBRAVO 20 MG / 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2711795 | SYMBRAVO 20 MG / 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2711795 | SYMBRAVO 20 MG / 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2711803 | menthol 2 % / methyl salicylate 10 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2711803 | menthol 2 % / methyl salicylate 10 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2711803 | menthol 2 % / methyl salicylate 10 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2711882 | Aphanamixis polystachya whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2711883 | Chamaecostus cuspidatus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2711885 | licorice root powder extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2711885 | licorice root powder extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2711886 | Rhododendron caucasicum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2711887 | Alchemilla vulgaris flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2711888 | Prolaxa | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2711889 | docusate sodium 250 MG [Prolaxa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2711890 | Prolaxa Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2711891 | Prolaxa Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2711892 | docusate Oral Capsule [Prolaxa] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2711894 | Prolaxa 250 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2711894 | Prolaxa 250 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2711894 | Prolaxa 250 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2711894 | Prolaxa 250 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 27120 | hordenine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2712044 | bevacizumab-nwgd | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2712045 | bevacizumab-nwgd 25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2712048 | bevacizumab-nwgd 100 MG in 4 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2712048 | bevacizumab-nwgd 100 MG in 4 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2712048 | bevacizumab-nwgd 100 MG in 4 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712049 | bevacizumab-nwgd 25 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2712049 | bevacizumab-nwgd 25 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2712050 | Jobevne | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2712051 | bevacizumab-nwgd 25 MG/ML [Jobevne] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2712052 | Jobevne Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2712053 | bevacizumab Injection [Jobevne] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2712055 | Jobevne 100 MG in 4 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2712055 | Jobevne 100 MG in 4 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2712055 | Jobevne 100 MG in 4 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712056 | Jobevne 25 MG/ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2712056 | Jobevne 25 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2712056 | Jobevne 25 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2712057 | bevacizumab-nwgd 400 MG in 16 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2712057 | bevacizumab-nwgd 400 MG in 16 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2712057 | bevacizumab-nwgd 400 MG in 16 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712058 | Jobevne 400 MG in 16 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2712058 | Jobevne 400 MG in 16 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2712058 | Jobevne 400 MG in 16 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712059 | Primacur | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 2712060 | fenbendazole 100 MG/ML [Primacur] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2712061 | Primacur Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2712062 | Primacur Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2712063 | fenbendazole Oral Suspension [Primacur] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2712064 | PRIMACUR 10 % Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2712064 | PRIMACUR 10 % Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2712064 | PRIMACUR 10 % Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2712064 | PRIMACUR 10 % Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2712065 | praziquantel 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2712066 | praziquantel Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 2712067 | praziquantel Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2712068 | praziquantel 5 % Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2712068 | praziquantel 5 % Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2712068 | praziquantel 5 % Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2712069 | landiolol hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2712070 | landiolol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2712071 | landiolol 280 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2712072 | landiolol Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2712073 | landiolol Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2712074 | landiolol 280 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712074 | landiolol 280 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2712074 | landiolol 280 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2712075 | Rapiblyk | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2712076 | landiolol 280 MG [Rapiblyk] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2712077 | Rapiblyk Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2712078 | landiolol Injection [Rapiblyk] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2712079 | Rapiblyk 280 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2712079 | Rapiblyk 280 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712079 | Rapiblyk 280 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2712080 | efgartigimod alfa-qvfc 200 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2712081 | efgartigimod alfa / hyaluronidase Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2712083 | efgartigimod alfa 1,000 MG / hyaluronidase-qvfc 10,000 UNT in 5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2712083 | efgartigimod alfa 1,000 MG / hyaluronidase-qvfc 10,000 UNT in 5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2712083 | efgartigimod alfa 1,000 MG / hyaluronidase-qvfc 10,000 UNT in 5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712084 | efgartigimod alfa-qvfc 200 MG/ML / hyaluronidase-qvfc 2000 UNT/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2712084 | efgartigimod alfa-qvfc 200 MG/ML / hyaluronidase-qvfc 2000 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2712085 | efgartigimod alfa-qvfc 200 MG/ML / hyaluronidase-qvfc 2000 UNT/ML [Vyvgart Hytrulo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2712086 | efgartigimod alfa / hyaluronidase Prefilled Syringe [Vyvgart Hytrulo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2712088 | VYVGART Hytrulo 1,000 MG / 10,000 UNT in 5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2712088 | VYVGART Hytrulo 1,000 MG / 10,000 UNT in 5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712088 | VYVGART Hytrulo 1,000 MG / 10,000 UNT in 5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2712089 | VYVGART Hytrulo 200 MG/ML / 2000 UNT/ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2712089 | VYVGART Hytrulo 200 MG/ML / 2000 UNT/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2712089 | VYVGART Hytrulo 200 MG/ML / 2000 UNT/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2712092 | Luizza 1.5/30 21 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 2712092 | Luizza 1.5/30 21 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2712092 | Luizza 1.5/30 21 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712142 | metoprolol tartrate 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2712143 | metoprolol Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2712144 | metoprolol Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2712147 | metoprolol tartrate 10 MG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2712147 | metoprolol tartrate 10 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712147 | metoprolol tartrate 10 MG in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2712148 | metoprolol tartrate 10 MG/ML [Lopressor] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2712149 | Lopressor Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2712150 | metoprolol Oral Solution [Lopressor] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2712152 | Lopressor 10 MG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2712152 | Lopressor 10 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712152 | Lopressor 10 MG in 1 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2712154 | zinc undecylenate 10 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2712154 | zinc undecylenate 10 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2712154 | zinc undecylenate 10 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2712155 | acetaminophen 325 MG / dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG per 10 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2712155 | acetaminophen 325 MG / dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG per 10 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2712155 | acetaminophen 325 MG / dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG per 10 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2712155 | acetaminophen 325 MG / dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG per 10 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2712155 | acetaminophen 325 MG / dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG per 10 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2712155 | acetaminophen 325 MG / dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG per 10 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2712155 | acetaminophen 325 MG / dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG per 10 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2712156 | acetaminophen 325 MG / guaiFENesin 200 MG / phenylephrine HCl 10 MG in 10 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2712156 | acetaminophen 325 MG / guaiFENesin 200 MG / phenylephrine HCl 10 MG in 10 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2712156 | acetaminophen 325 MG / guaiFENesin 200 MG / phenylephrine HCl 10 MG in 10 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2712156 | acetaminophen 325 MG / guaiFENesin 200 MG / phenylephrine HCl 10 MG in 10 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2712156 | acetaminophen 325 MG / guaiFENesin 200 MG / phenylephrine HCl 10 MG in 10 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2712156 | acetaminophen 325 MG / guaiFENesin 200 MG / phenylephrine HCl 10 MG in 10 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2712156 | acetaminophen 325 MG / guaiFENesin 200 MG / phenylephrine HCl 10 MG in 10 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2712157 | dextromethorphan HBr 30 MG / pyrilamine maleate 50 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2712157 | dextromethorphan HBr 30 MG / pyrilamine maleate 50 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2712157 | dextromethorphan HBr 30 MG / pyrilamine maleate 50 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2712158 | BETADINE 5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2712158 | BETADINE 5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2712158 | BETADINE 5 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2712219 | Phenylpro | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 2712220 | phenylpropanolamine hydrochloride 25 MG [Phenylpro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2712221 | Phenylpro Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2712222 | Phenylpro Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2712223 | Phenylpro Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2712224 | phenylpropanolamine Chewable Tablet [Phenylpro] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2712226 | PhenylPro 25 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2712226 | PhenylPro 25 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2712226 | PhenylPro 25 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2712227 | phenylpropanolamine hydrochloride 50 MG [Phenylpro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2712228 | PhenylPro 50 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2712228 | PhenylPro 50 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2712228 | PhenylPro 50 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2712229 | phenylpropanolamine hydrochloride 75 MG [Phenylpro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2712230 | PhenylPro 75 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2712230 | PhenylPro 75 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2712230 | PhenylPro 75 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2712231 | thiotepa 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2712232 | thiotepa 200 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2712232 | thiotepa 200 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2712232 | thiotepa 200 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712233 | thiotepa 200 MG [Tepadina] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2712234 | TEPADINA 200 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2712234 | TEPADINA 200 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712234 | TEPADINA 200 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2712234 | TEPADINA 200 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712235 | olaflur | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2712236 | miconazole nitrate 15 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2712237 | miconazole nitrate 1.5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2712237 | miconazole nitrate 1.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2712237 | miconazole nitrate 1.5 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2712344 | bumetanide 0.25 MG in 10 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2712344 | bumetanide 0.25 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2712344 | bumetanide 0.25 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712344 | bumetanide 0.25 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712345 | Doracide | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 2712346 | doramectin 5 MG/ML [Doracide] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2712347 | Doracide Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2712348 | doramectin Topical Solution [Doracide] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2712349 | DORACIDE Pour-On for Cattle 0.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2712349 | DORACIDE Pour-On for Cattle 0.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2712349 | DORACIDE Pour-On for Cattle 0.5 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2712352 | sirolimus protein-bound | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2712446 | isopropyl alcohol 0.17 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2712447 | ethanol 55 % / isopropyl alcohol 17 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2712447 | ethanol 55 % / isopropyl alcohol 17 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2712447 | ethanol 55 % / isopropyl alcohol 17 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2712450 | Clemasz | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2712451 | clemastine fumarate 2.68 MG [Clemasz] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2712452 | Clemasz Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2712453 | Clemasz Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2712454 | clemastine Oral Tablet [Clemasz] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2712456 | CLEMASZ 2.68 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2712456 | CLEMASZ 2.68 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2712456 | CLEMASZ 2.68 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712460 | maralixibat 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2712461 | maralixibat Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2712462 | maralixibat Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2712463 | maralixibat 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712463 | maralixibat 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2712463 | maralixibat 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2712464 | maralixibat 10 MG [Livmarli] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2712465 | Livmarli Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2712466 | maralixibat Oral Tablet [Livmarli] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2712467 | Livmarli 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712467 | Livmarli 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2712467 | Livmarli 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712467 | Livmarli 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2712468 | maralixibat 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2712469 | maralixibat 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712469 | maralixibat 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2712469 | maralixibat 20 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2712470 | maralixibat 20 MG [Livmarli] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2712471 | Livmarli 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712471 | Livmarli 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2712471 | Livmarli 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712471 | Livmarli 20 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2712472 | maralixibat 30 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2712473 | maralixibat 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712473 | maralixibat 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2712473 | maralixibat 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2712474 | maralixibat 30 MG [Livmarli] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2712475 | Livmarli 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712475 | Livmarli 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2712475 | Livmarli 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712475 | Livmarli 30 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2712476 | maralixibat 15 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2712477 | maralixibat 15 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712477 | maralixibat 15 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2712477 | maralixibat 15 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2712478 | maralixibat 15 MG [Livmarli] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2712479 | Livmarli 15 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712479 | Livmarli 15 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2712479 | Livmarli 15 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712479 | Livmarli 15 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2712480 | salicylic acid 1 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2712480 | salicylic acid 1 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2712480 | salicylic acid 1 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2712481 | Flurbipro | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 2712482 | flurbiprofen 100 MG [Flurbipro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2712483 | Flurbipro Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2712484 | Flurbipro Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2712485 | flurbiprofen Oral Tablet [Flurbipro] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2712486 | FlurbiPro 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2712486 | FlurbiPro 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2712486 | FlurbiPro 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2712487 | Lurbipr | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2712488 | flurbiprofen 100 MG [Lurbipr] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2712489 | Lurbipr Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2712490 | Lurbipr Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2712491 | flurbiprofen Oral Tablet [Lurbipr] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2712492 | LURBIPR 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2712492 | LURBIPR 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2712492 | LURBIPR 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712542 | penpulimab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2712545 | Chamaelirium luteum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2712546 | ensartinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2712547 | ensartinib hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2712548 | ethanol 55 % / isopropyl alcohol 17 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2712548 | ethanol 55 % / isopropyl alcohol 17 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2712548 | ethanol 55 % / isopropyl alcohol 17 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2712620 | Enropro Silver | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 2712621 | enrofloxacin 5 MG/ML / silver sulfadiazine 10 MG/ML [Enropro Silver] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2712621 | enrofloxacin 5 MG/ML / silver sulfadiazine 10 MG/ML [Enropro Silver] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2712622 | Enropro Silver Otic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2712623 | enrofloxacin / silver sulfadiazine Otic Solution [Enropro Silver] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2712623 | enrofloxacin / silver sulfadiazine Otic Solution [Enropro Silver] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2712624 | EnroPro Silver 0.5 % / 1 % Otic Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2712624 | EnroPro Silver 0.5 % / 1 % Otic Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2712624 | EnroPro Silver 0.5 % / 1 % Otic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2712624 | EnroPro Silver 0.5 % / 1 % Otic Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2712624 | EnroPro Silver 0.5 % / 1 % Otic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2712630 | ensartinib 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2712631 | ensartinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2712632 | ensartinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2712633 | ensartinib Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2712634 | ensartinib 100 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712634 | ensartinib 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2712634 | ensartinib 100 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2712635 | Ensacove | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2712636 | ensartinib 100 MG [Ensacove] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2712637 | Ensacove Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2712638 | Ensacove Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2712639 | ensartinib Oral Capsule [Ensacove] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2712640 | Ensacove 100 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712640 | Ensacove 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2712640 | Ensacove 100 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2712641 | ensartinib 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2712642 | ensartinib 25 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712642 | ensartinib 25 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2712642 | ensartinib 25 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2712643 | ensartinib 25 MG [Ensacove] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2712644 | Ensacove 25 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712644 | Ensacove 25 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2712644 | Ensacove 25 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2712646 | penpulimab-kcqx | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2712647 | penpulimab-kcqx 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2712648 | penpulimab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2712649 | penpulimab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2712652 | penpulimab-kcqx 100 MG in 10 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2712652 | penpulimab-kcqx 100 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2712652 | penpulimab-kcqx 100 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712653 | penpulimab-kcqx 10 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2712656 | Pelargonium sidoides whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2712683 | Zelvysia | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2712684 | sapropterin dihydrochloride 100 MG [Zelvysia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2712685 | Zelvysia Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2712686 | Zelvysia Oral Powder Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2712687 | sapropterin Powder for Oral Solution [Zelvysia] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2712689 | Zelvysia 100 MG Powder for Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2712689 | Zelvysia 100 MG Powder for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2712689 | Zelvysia 100 MG Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712690 | sapropterin dihydrochloride 500 MG [Zelvysia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2712691 | Zelvysia 500 MG Powder for Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2712691 | Zelvysia 500 MG Powder for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2712691 | Zelvysia 500 MG Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712692 | nipocalimab-aahu | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2712693 | nipocalimab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2712694 | nipocalimab-aahu 185 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2712695 | nipocalimab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2712696 | nipocalimab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2712699 | nipocalimab-aahu 300 MG in 1.62 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2712699 | nipocalimab-aahu 300 MG in 1.62 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2712699 | nipocalimab-aahu 300 MG in 1.62 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712700 | nipocalimab-aahu 185 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2712700 | nipocalimab-aahu 185 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2712701 | Imaavy | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2712702 | nipocalimab-aahu 185 MG/ML [Imaavy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2712703 | Imaavy Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2712704 | nipocalimab Injection [Imaavy] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2712706 | imaavy 300 MG in 1.62 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2712706 | imaavy 300 MG in 1.62 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2712706 | imaavy 300 MG in 1.62 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712707 | imaavy 185 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2712707 | imaavy 185 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2712707 | imaavy 185 MG/ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2712708 | nipocalimab-aahu 1,200 MG in 6.5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2712708 | nipocalimab-aahu 1,200 MG in 6.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2712708 | nipocalimab-aahu 1,200 MG in 6.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712709 | imaavy 1,200 MG in 6.5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2712709 | imaavy 1,200 MG in 6.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2712709 | imaavy 1,200 MG in 6.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2712712 | prednisoLONE 2 MG / trimeprazine 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2712712 | prednisoLONE 2 MG / trimeprazine 5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2712712 | prednisoLONE 2 MG / trimeprazine 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2712712 | prednisoLONE 2 MG / trimeprazine 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2712712 | prednisoLONE 2 MG / trimeprazine 5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2712713 | Cortamine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 2712714 | prednisolone 2 MG / trimeprazine 5 MG [Cortamine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2712714 | prednisolone 2 MG / trimeprazine 5 MG [Cortamine] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2712715 | Cortamine Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2712716 | Cortamine Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2712717 | prednisolone / trimeprazine Oral Tablet [Cortamine] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2712717 | prednisolone / trimeprazine Oral Tablet [Cortamine] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2712718 | Cortamine P 5 MG / 2 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2712718 | Cortamine P 5 MG / 2 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2712718 | Cortamine P 5 MG / 2 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2712718 | Cortamine P 5 MG / 2 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2712796 | salicylic acid 12 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2712796 | salicylic acid 12 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2712796 | salicylic acid 12 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 27130 | cefpirome | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 27130 | cefpirome | Designated preferred name (PT) | NO | |
RxCUI: 27130 | cefpirome | Full form of descriptor (FN) | NO | |
RxCUI: 27130 | cefpirome | Designated preferred name (PT) | NO | |
RxCUI: 27130 | cefpirome | Full form of descriptor (FN) | NO | |
RxCUI: 2713296 | benzocaine 7.5 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2713296 | benzocaine 7.5 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2713296 | benzocaine 7.5 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2713297 | gentamicin 8.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2713298 | posaconazole 2.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2713299 | mometasone furoate 2.1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2713300 | gentamicin / mometasone / posaconazole | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
RxCUI: 2713301 | gentamicin / mometasone / posaconazole Otic Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 2713302 | gentamicin / mometasone / posaconazole Otic Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2713305 | gentamicin 8.6 MG/ML / mometasone furoate 2.1 MG/ML / posaconazole 2.6 MG/ML Otic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2713305 | gentamicin 8.6 MG/ML / mometasone furoate 2.1 MG/ML / posaconazole 2.6 MG/ML Otic Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2713305 | gentamicin 8.6 MG/ML / mometasone furoate 2.1 MG/ML / posaconazole 2.6 MG/ML Otic Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2713306 | Mometamax Single | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 2713307 | gentamicin 8.6 MG/ML / mometasone furoate 2.1 MG/ML / posaconazole 2.6 MG/ML [Mometamax Single] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2713308 | Mometamax Single Otic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2713309 | gentamicin / mometasone / posaconazole Otic Suspension [Mometamax Single] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2713311 | Mometamax Single 8.6 MG/ML / 2.6 MG/ML / 2.1 MG/ML Otic Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2713311 | Mometamax Single 8.6 MG/ML / 2.6 MG/ML / 2.1 MG/ML Otic Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2713311 | Mometamax Single 8.6 MG/ML / 2.6 MG/ML / 2.1 MG/ML Otic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2713312 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2713312 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2713312 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2713313 | 1 daytime (acetaminophen 325 MG / dextromethorphan HBr 10 MG Oral Tablet) / 1 nighttime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG Oral Tablet) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
RxCUI: 2713313 | 1 daytime (acetaminophen 325 MG / dextromethorphan HBr 10 MG Oral Tablet) / 1 nighttime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG Oral Tablet) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2713313 | 1 daytime (acetaminophen 325 MG / dextromethorphan HBr 10 MG Oral Tablet) / 1 nighttime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG Oral Tablet) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2713314 | prademagene zamikeracel | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2713344 | prademagene zamikeracel 41.3 SQCM | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2713345 | prademagene zamikeracel Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2713346 | prademagene zamikeracel Medicated Patch | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2713347 | prademagene zamikeracel 41.25 SQCM Cellular Sheet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2713347 | prademagene zamikeracel 41.25 SQCM Cellular Sheet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2713347 | prademagene zamikeracel 41.25 SQCM Cellular Sheet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2713348 | Zevaskyn | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2713349 | prademagene zamikeracel 41.3 SQCM [Zevaskyn] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2713350 | Zevaskyn Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2713351 | prademagene zamikeracel Medicated Patch [Zevaskyn] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2713352 | zevaskyn 41.25 SQCM Cellular Sheet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2713352 | zevaskyn 41.25 SQCM Cellular Sheet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2713352 | zevaskyn 41.25 SQCM Cellular Sheet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2713709 | ARIPiprazole 15 MG Oral Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2713709 | ARIPiprazole 15 MG Oral Film | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2713709 | ARIPiprazole 15 MG Oral Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2713737 | EPINEPHrine 5 MG in 250 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2713737 | EPINEPHrine 5 MG in 250 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2713737 | EPINEPHrine 5 MG in 250 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2713737 | EPINEPHrine 5 MG in 250 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2713737 | EPINEPHrine 5 MG in 250 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2713737 | EPINEPHrine 5 MG in 250 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2713737 | EPINEPHrine 5 MG in 250 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2713738 | epinephrine 0.02 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2713738 | epinephrine 0.02 MG/ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2713739 | epinephrine 0.02 MG/ML [Adrenalin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2713739 | epinephrine 0.02 MG/ML [Adrenalin] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2713740 | Adrenalin 5 MG in 250 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2713740 | Adrenalin 5 MG in 250 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2713740 | Adrenalin 5 MG in 250 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2713740 | Adrenalin 5 MG in 250 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2713740 | Adrenalin 5 MG in 250 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2713741 | epinephrine 0.02 MG/ML Injection [Adrenalin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2713741 | epinephrine 0.02 MG/ML Injection [Adrenalin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2713741 | epinephrine 0.02 MG/ML Injection [Adrenalin] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2713742 | alpha-tocopherol acetate 0.002 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2713743 | silicon dioxide 0.15 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2713744 | alpha tocopherol / silicon dioxide / sodium fluoride | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
RxCUI: 2713745 | alpha tocopherol / silicon dioxide / sodium fluoride Dental Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 2713746 | alpha tocopherol / silicon dioxide / sodium fluoride Paste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 2713747 | alpha tocopherol / silicon dioxide / sodium fluoride Oral Paste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 2713748 | alpha tocopherol / silicon dioxide / sodium fluoride Toothpaste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 2713749 | alpha tocopherol / silicon dioxide / sodium fluoride Toothpaste | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2713755 | alpha-tocopherol acetate 0.2 % / silicon dioxide 15 % / sodium fluoride 0.22 % Toothpaste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2713755 | alpha-tocopherol acetate 0.2 % / silicon dioxide 15 % / sodium fluoride 0.22 % Toothpaste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2713755 | alpha-tocopherol acetate 0.2 % / silicon dioxide 15 % / sodium fluoride 0.22 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2713796 | sodium bicarbonate 8.4 MG in 0.1 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2713796 | sodium bicarbonate 8.4 MG in 0.1 ML Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2713796 | sodium bicarbonate 8.4 MG in 0.1 ML Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2713796 | sodium bicarbonate 8.4 MG in 0.1 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2713796 | sodium bicarbonate 8.4 MG in 0.1 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2713885 | ustekinumab-ttwe 45 MG in 0.5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2713885 | ustekinumab-ttwe 45 MG in 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2713885 | ustekinumab-ttwe 45 MG in 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2713886 | ustekinumab-ttwe 90 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2713886 | ustekinumab-ttwe 90 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2713887 | Pyzchiva 45 MG in 0.5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2713887 | Pyzchiva 45 MG in 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2713887 | Pyzchiva 45 MG in 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2713888 | Pyzchiva 90 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2713888 | Pyzchiva 90 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2713888 | Pyzchiva 90 MG/ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2713889 | vitamin A 0.25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2713890 | ascorbic acid / cholecalciferol / vitamin A Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2713891 | ascorbic acid 50 MG / cholecalciferol 10 MCG / vitamin A 250 MCG in 1 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2713891 | ascorbic acid 50 MG / cholecalciferol 10 MCG / vitamin A 250 MCG in 1 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2713891 | ascorbic acid 50 MG / cholecalciferol 10 MCG / vitamin A 250 MCG in 1 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2713891 | ascorbic acid 50 MG / cholecalciferol 10 MCG / vitamin A 250 MCG in 1 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2713891 | ascorbic acid 50 MG / cholecalciferol 10 MCG / vitamin A 250 MCG in 1 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714 | Collagen | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2714 | Collagen | Designated preferred name (PT) | YES | |
RxCUI: 2714 | Collagen | Full form of descriptor (FN) | YES | |
RxCUI: 2714 | Collagen | Designated preferred name (PT) | YES | |
RxCUI: 2714 | Collagen | Full form of descriptor (FN) | YES | |
RxCUI: 2714099 | salicylic acid 12 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2714099 | salicylic acid 12 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2714099 | salicylic acid 12 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2714170 | cyanocobalamin 2000 MCG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2714170 | cyanocobalamin 2000 MCG Disintegrating Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714170 | cyanocobalamin 2000 MCG Disintegrating Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2714171 | cholecalciferol Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2714172 | vitamin D3 10 MCG (400 UNT) in 1 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2714172 | vitamin D3 10 MCG (400 UNT) in 1 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714172 | vitamin D3 10 MCG (400 UNT) in 1 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2714172 | vitamin D3 10 MCG (400 UNT) in 1 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714174 | Bucapsol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2714175 | buspirone hydrochloride 7.5 MG [Bucapsol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2714175 | buspirone hydrochloride 7.5 MG [Bucapsol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2714176 | Bucapsol Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2714177 | Bucapsol Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2714178 | buspirone Oral Capsule [Bucapsol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2714178 | buspirone Oral Capsule [Bucapsol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2714179 | buspirone hydrochloride Oral Capsule [Bucapsol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2714180 | Bucapsol 7.5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2714180 | Bucapsol 7.5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714180 | Bucapsol 7.5 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2714180 | Bucapsol 7.5 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2714181 | buspirone hydrochloride 10 MG [Bucapsol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2714181 | buspirone hydrochloride 10 MG [Bucapsol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2714182 | Bucapsol 10 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2714182 | Bucapsol 10 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714182 | Bucapsol 10 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2714182 | Bucapsol 10 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2714183 | buspirone hydrochloride 15 MG [Bucapsol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2714183 | buspirone hydrochloride 15 MG [Bucapsol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2714184 | Bucapsol 15 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2714184 | Bucapsol 15 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714184 | Bucapsol 15 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2714184 | Bucapsol 15 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2714185 | dihydroergotamine 5.2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2714186 | dihydroergotamine Nasal Powder | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2714187 | dihydroergotamine 5.2 MG Nasal Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714187 | dihydroergotamine 5.2 MG Nasal Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714187 | dihydroergotamine 5.2 MG Nasal Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2714187 | dihydroergotamine 5.2 MG Nasal Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2714188 | Atzumi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2714189 | dihydroergotamine 5.2 MG [Atzumi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2714190 | Atzumi Nasal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2714191 | dihydroergotamine Nasal Powder [Atzumi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2714192 | Atzumi 5.2 MG Nasal Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2714192 | Atzumi 5.2 MG Nasal Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714192 | Atzumi 5.2 MG Nasal Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714192 | Atzumi 5.2 MG Nasal Powder | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2714197 | polymyxin B 0.5 UNT/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2714198 | bacitracin 400 UNT / neomycin 3.5 MG / polymyxin B 500 UNT per GM Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2714198 | bacitracin 400 UNT / neomycin 3.5 MG / polymyxin B 500 UNT per GM Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2714198 | bacitracin 400 UNT / neomycin 3.5 MG / polymyxin B 500 UNT per GM Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2714234 | iloperidone 1 MG Oral Tablet (4) / iloperidone 2 MG Oral Tablet (2) / iloperidone 6 MG Oral Tablet (2) Titration Pack C | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
RxCUI: 2714234 | iloperidone 1 MG Oral Tablet (4) / iloperidone 2 MG Oral Tablet (2) / iloperidone 6 MG Oral Tablet (2) Titration Pack C | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2714234 | iloperidone 1 MG Oral Tablet (4) / iloperidone 2 MG Oral Tablet (2) / iloperidone 6 MG Oral Tablet (2) Titration Pack C | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714235 | Fanapt Titration Pack C | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 2714235 | Fanapt Titration Pack C | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2714235 | Fanapt Titration Pack C | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714236 | telisotuzumab vedotin-tllv | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2714237 | telisotuzumab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2714240 | telisotuzumab vedotin-tllv 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2714241 | telisotuzumab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2714242 | telisotuzumab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2714245 | telisotuzumab vedotin-tllv 100 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2714245 | telisotuzumab vedotin-tllv 100 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2714246 | Emrelis | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2714247 | telisotuzumab vedotin-tllv 100 MG [Emrelis] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2714248 | Emrelis Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2714249 | telisotuzumab Injection [Emrelis] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2714251 | Emrelis 100 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2714251 | Emrelis 100 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714251 | Emrelis 100 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2714252 | telisotuzumab vedotin-tllv 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2714253 | telisotuzumab vedotin-tllv 20 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2714253 | telisotuzumab vedotin-tllv 20 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2714254 | telisotuzumab vedotin-tllv 20 MG [Emrelis] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2714255 | Emrelis 20 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2714255 | Emrelis 20 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714255 | Emrelis 20 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2714306 | dihydroergotamine Auto-Injector | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2714308 | dihydroergotamine mesylate 1 MG in 1 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714308 | dihydroergotamine mesylate 1 MG in 1 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2714308 | dihydroergotamine mesylate 1 MG in 1 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714308 | dihydroergotamine mesylate 1 MG in 1 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2714309 | DHE mesylate 1 MG/ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2714309 | DHE mesylate 1 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2714310 | Brekiya | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2714311 | dihydroergotamine mesylate 1 MG/ML [Brekiya] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2714312 | Brekiya Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2714313 | dihydroergotamine Auto-Injector [Brekiya] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2714315 | brekiya 1 MG in 1 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714315 | brekiya 1 MG in 1 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714315 | brekiya 1 MG in 1 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2714315 | brekiya 1 MG in 1 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714315 | brekiya 1 MG in 1 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2714316 | dihydroergotamine mesylate 1 MG/ML Auto-Injector [Brekiya] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2714316 | dihydroergotamine mesylate 1 MG/ML Auto-Injector [Brekiya] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2714316 | dihydroergotamine mesylate 1 MG/ML Auto-Injector [Brekiya] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2714498 | Rhamnus cathartica bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2714500 | Agave tequilana inulin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2714501 | defactinib hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2714502 | defactinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2714503 | defactinib 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2714504 | defactinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2714505 | defactinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2714506 | defactinib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2714507 | defactinib 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714507 | defactinib 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2714507 | defactinib 200 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2714508 | Fakzynja | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2714509 | defactinib 200 MG [Fakzynja] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2714510 | Fakzynja Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2714511 | Fakzynja Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2714512 | defactinib Oral Tablet [Fakzynja] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2714513 | FAKZYNJA 200 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2714513 | FAKZYNJA 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714513 | FAKZYNJA 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2714514 | avutometinib potassium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2714515 | avutometinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2714516 | avutometinib 0.8 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2714517 | avutometinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2714518 | avutometinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2714519 | avutometinib Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2714520 | avutometinib 0.8 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714520 | avutometinib 0.8 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2714520 | avutometinib 0.8 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2714521 | Avmapki | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2714522 | avutometinib 0.8 MG [Avmapki] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2714523 | Avmapki Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2714524 | Avmapki Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2714525 | avutometinib Oral Capsule [Avmapki] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2714526 | AVMAPKI 0.8 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714526 | AVMAPKI 0.8 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2714526 | AVMAPKI 0.8 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2714607 | benzalkonium chloride 0.06 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2714607 | benzalkonium chloride 0.06 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2714607 | benzalkonium chloride 0.06 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2714655 | hydrocortisone 0.001 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2714656 | hydrocortisone 0.1 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2714656 | hydrocortisone 0.1 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2714656 | hydrocortisone 0.1 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2714657 | Luizza 1/20 21 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 2714657 | Luizza 1/20 21 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2714657 | Luizza 1/20 21 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714658 | treprostinil 0.0265 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2714659 | treprostinil 26.5 MCG Inhalation Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2714659 | treprostinil 26.5 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714659 | treprostinil 26.5 MCG Inhalation Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2714659 | treprostinil 26.5 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714660 | Yutrepia | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2714661 | treprostinil 0.0265 MG [Yutrepia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2714662 | Yutrepia Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2714663 | treprostinil Inhalation Powder [Yutrepia] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2714664 | Yutrepia 26.5 MCG Inhalation Powder | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2714664 | Yutrepia 26.5 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714664 | Yutrepia 26.5 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714664 | Yutrepia 26.5 MCG Inhalation Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2714664 | Yutrepia 26.5 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714665 | treprostinil 0.053 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2714666 | treprostinil 53 MCG Inhalation Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2714666 | treprostinil 53 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714666 | treprostinil 53 MCG Inhalation Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2714666 | treprostinil 53 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714667 | treprostinil 0.053 MG [Yutrepia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2714668 | Yutrepia 53 MCG Inhalation Powder | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2714668 | Yutrepia 53 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714668 | Yutrepia 53 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714668 | Yutrepia 53 MCG Inhalation Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2714668 | Yutrepia 53 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714669 | treprostinil 0.0795 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2714670 | treprostinil 79.5 MCG Inhalation Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2714670 | treprostinil 79.5 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714670 | treprostinil 79.5 MCG Inhalation Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2714670 | treprostinil 79.5 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714671 | treprostinil 0.0795 MG [Yutrepia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2714672 | Yutrepia 79.5 MCG Inhalation Powder | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2714672 | Yutrepia 79.5 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714672 | Yutrepia 79.5 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714672 | Yutrepia 79.5 MCG Inhalation Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2714672 | Yutrepia 79.5 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714673 | treprostinil 0.106 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2714674 | treprostinil 106 MCG Inhalation Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2714674 | treprostinil 106 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714674 | treprostinil 106 MCG Inhalation Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2714674 | treprostinil 106 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714675 | treprostinil 0.106 MG [Yutrepia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2714676 | Yutrepia 106 MCG Inhalation Powder | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2714676 | Yutrepia 106 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714676 | Yutrepia 106 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714676 | Yutrepia 106 MCG Inhalation Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2714676 | Yutrepia 106 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714704 | miconazole 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2714705 | menthol / miconazole | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
RxCUI: 2714706 | menthol / miconazole Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 2714707 | menthol / miconazole Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2714708 | menthol 8 % / miconazole 0.1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2714708 | menthol 8 % / miconazole 0.1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2714708 | menthol 8 % / miconazole 0.1 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2714709 | Rhinomel | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 2714710 | sodium chloride 9 MG/ML [Rhinomel] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2714711 | Rhinomel Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2714712 | Rhinomel Nasal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2714713 | sodium chloride Nasal Spray [Rhinomel] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2714714 | RHINOMEL MANUKA 0.9 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2714714 | RHINOMEL MANUKA 0.9 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2714714 | RHINOMEL MANUKA 0.9 % Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2714714 | RHINOMEL MANUKA 0.9 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2714714 | RHINOMEL MANUKA 0.9 % Nasal Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2714921 | avutometinib 0.8 MG Oral Capsule / defactinib 200 MG Oral Tablet Co-Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
RxCUI: 2714921 | avutometinib 0.8 MG Oral Capsule / defactinib 200 MG Oral Tablet Co-Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2714921 | avutometinib 0.8 MG Oral Capsule / defactinib 200 MG Oral Tablet Co-Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714922 | AVMAPKI FAKZYNJA Co-Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 2714922 | AVMAPKI FAKZYNJA Co-Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2714922 | AVMAPKI FAKZYNJA Co-Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714923 | Nuvaxovid 2024-2025 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2714924 | SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2705 0.01 MG/ML [Nuvaxovid 2024-2025] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2714925 | Nuvaxovid 2024-2025 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2714926 | SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein Prefilled Syringe [Nuvaxovid 2024-2025] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2714928 | NUVAXOVID 2024-2025 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2714928 | NUVAXOVID 2024-2025 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2714928 | NUVAXOVID 2024-2025 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2714929 | NUVAXOVID 2024-2025 vaccine 0.01 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2714929 | NUVAXOVID 2024-2025 vaccine 0.01 MG/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2714929 | NUVAXOVID 2024-2025 vaccine 0.01 MG/ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 27152 | PPP - Human pancreatic polypeptide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 27152 | PPP - Human pancreatic polypeptide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2715382 | denosumab-bbdz | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2715383 | denosumab-bbdz 70 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2715386 | denosumab-bbdz 120 MG in 1.7 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2715386 | denosumab-bbdz 120 MG in 1.7 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2715386 | denosumab-bbdz 120 MG in 1.7 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2715387 | denosumab-bbdz 70 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2715388 | Wyost | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2715389 | denosumab-bbdz 70 MG/ML [Wyost] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2715390 | Wyost Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2715391 | denosumab Injection [Wyost] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2715393 | Wyost 120 MG in 1.7 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2715393 | Wyost 120 MG in 1.7 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2715393 | Wyost 120 MG in 1.7 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2715393 | Wyost 120 MG in 1.7 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2715394 | denosumab-bbdz 70 MG/ML Injection [Wyost] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2715394 | denosumab-bbdz 70 MG/ML Injection [Wyost] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2715395 | lidocaine HCl 4 % / menthol 5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2715395 | lidocaine HCl 4 % / menthol 5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2715395 | lidocaine HCl 4 % / menthol 5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2715398 | phenylephrine hydrochloride 0.25 % Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2715398 | phenylephrine hydrochloride 0.25 % Rectal Suppository | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2715398 | phenylephrine hydrochloride 0.25 % Rectal Suppository | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2715399 | aflibercept-yszy | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2715400 | aflibercept-yszy 40 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2715403 | aflibercept-yszy 2 MG in 0.05 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2715403 | aflibercept-yszy 2 MG in 0.05 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2715403 | aflibercept-yszy 2 MG in 0.05 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2715404 | aflibercept-yszy 40 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2715405 | Opuviz | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2715406 | aflibercept-yszy 40 MG/ML [Opuviz] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2715407 | Opuviz Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2715408 | aflibercept Injection [Opuviz] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2715410 | Opuviz 2 MG in 0.05 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2715410 | Opuviz 2 MG in 0.05 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2715410 | Opuviz 2 MG in 0.05 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2715410 | Opuviz 2 MG in 0.05 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2715411 | aflibercept-yszy 40 MG/ML Injection [Opuviz] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2715411 | aflibercept-yszy 40 MG/ML Injection [Opuviz] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2715412 | doxylamine succinate 6.25 MG per 15 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2715412 | doxylamine succinate 6.25 MG per 15 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2715412 | doxylamine succinate 6.25 MG per 15 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2715452 | insulin, regular, human 30 Inhalation Cartridge Sample Pack - 15 (4 UNT), 15 (8 UNT) | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
RxCUI: 2715452 | insulin, regular, human 30 Inhalation Cartridge Sample Pack - 15 (4 UNT), 15 (8 UNT) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2715452 | insulin, regular, human 30 Inhalation Cartridge Sample Pack - 15 (4 UNT), 15 (8 UNT) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2715453 | afrezza 30 Inhalation Cartridge Sample Pack - 15 (4 UNT), 15 (8 UNT) | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 2715453 | afrezza 30 Inhalation Cartridge Sample Pack - 15 (4 UNT), 15 (8 UNT) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2715453 | afrezza 30 Inhalation Cartridge Sample Pack - 15 (4 UNT), 15 (8 UNT) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2715454 | nilotinib d-tartrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2715455 | nilotinib d-tartrate 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2715459 | nilotinib d-tartrate 50 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2715459 | nilotinib d-tartrate 50 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2715459 | nilotinib d-tartrate 50 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2715460 | Nilceya | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 2715468 | nilotinib d-tartrate 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2715469 | nilotinib d-tartrate 150 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2715469 | nilotinib d-tartrate 150 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2715469 | nilotinib d-tartrate 150 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2715472 | nilotinib d-tartrate 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2715473 | nilotinib d-tartrate 200 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2715473 | nilotinib d-tartrate 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2715473 | nilotinib d-tartrate 200 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2715511 | denosumab-bbdz 60 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2715513 | denosumab-bbdz 60 MG in 1 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2715513 | denosumab-bbdz 60 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2715513 | denosumab-bbdz 60 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2715514 | denosumab-bbdz 60 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2715515 | Jubbonti | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2715516 | denosumab-bbdz 60 MG/ML [Jubbonti] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2715517 | Jubbonti Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2715518 | denosumab Prefilled Syringe [Jubbonti] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2715520 | Jubbonti 60 MG in 1 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2715520 | Jubbonti 60 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2715520 | Jubbonti 60 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2715520 | Jubbonti 60 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2715521 | denosumab-bbdz 60 MG/ML Prefilled Syringe [Jubbonti] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2715521 | denosumab-bbdz 60 MG/ML Prefilled Syringe [Jubbonti] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2715602 | biotin / minoxidil Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2715603 | biotin 0.5 % / minoxidil 5 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2715603 | biotin 0.5 % / minoxidil 5 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2715603 | biotin 0.5 % / minoxidil 5 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2715604 | acetaminophen 650 MG in 65 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2715604 | acetaminophen 650 MG in 65 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2715604 | acetaminophen 650 MG in 65 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2715604 | acetaminophen 650 MG in 65 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2715855 | dextrose 10 % in 50 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2715855 | dextrose 10 % in 50 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2715855 | dextrose 10 % in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2715858 | doxylamine succinate 3.125 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2715859 | acetaminophen / dextromethorphan / doxylamine Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 2715860 | acetaminophen / dextromethorphan / doxylamine Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2715863 | acetaminophen 162.5 MG / dextromethorphan HBr 5 MG / doxylamine succinate 3.125 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2715863 | acetaminophen 162.5 MG / dextromethorphan HBr 5 MG / doxylamine succinate 3.125 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2715863 | acetaminophen 162.5 MG / dextromethorphan HBr 5 MG / doxylamine succinate 3.125 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2715864 | amdinocillin pivoxil 185 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2715865 | pivmecillinam 185 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2715865 | pivmecillinam 185 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2715865 | pivmecillinam 185 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2715866 | Pivya | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2715867 | amdinocillin pivoxil 185 MG [Pivya] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2715868 | Pivya Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2715869 | Pivya Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2715870 | amdinocillin pivoxil Oral Tablet [Pivya] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2715871 | Pivya 185 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2715871 | Pivya 185 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2715871 | Pivya 185 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2715871 | Pivya 185 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2716393 | Epimedium pubescens whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2716396 | desogest-eth estra 0.15-0.03 MG (21) Oral Tablet / ferrous bisglycinate 36.5 MG (7) Oral Tablet 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2716396 | desogest-eth estra 0.15-0.03 MG (21) Oral Tablet / ferrous bisglycinate 36.5 MG (7) Oral Tablet 28 Day Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
RxCUI: 2716396 | desogest-eth estra 0.15-0.03 MG (21) Oral Tablet / ferrous bisglycinate 36.5 MG (7) Oral Tablet 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2716397 | Averi 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 2716397 | Averi 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2716397 | Averi 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2716398 | Lidoguard | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 2716399 | lidocaine hydrochloride 40 MG/ML [Lidoguard] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2716400 | Lidoguard Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2716401 | lidocaine Topical Cream [Lidoguard] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2716403 | LidoGuard 4 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2716403 | LidoGuard 4 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2716403 | LidoGuard 4 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2716403 | LidoGuard 4 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2716404 | Bonsity | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2716405 | teriparatide 0.02 MG/ACTUAT [Bonsity] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2716406 | Bonsity Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2716407 | teriparatide Pen Injector [Bonsity] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2716408 | BONSITY 20 MCG/Dose in 28 Dose Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2716408 | BONSITY 20 MCG/Dose in 28 Dose Pen Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2716408 | BONSITY 20 MCG/Dose in 28 Dose Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2716409 | BONSITY 0.02 MG/ACTUAT Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2716409 | BONSITY 0.02 MG/ACTUAT Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2716409 | BONSITY 0.02 MG/ACTUAT Pen Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2716481 | Sitagliptin hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2716481 | Sitagliptin hydrochloride | Designated preferred name (PT) | NO | |
RxCUI: 2716481 | Sitagliptin hydrochloride | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2716481 | Sitagliptin hydrochloride | Full form of descriptor (FN) | NO | |
RxCUI: 2716482 | sitagliptin 25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2716482 | sitagliptin 25 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2716483 | sitagliptin Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2716483 | sitagliptin Oral Liquid Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2716484 | sitagliptin Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2716484 | sitagliptin Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2716485 | SITagliptin 25 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2716485 | SITagliptin 25 MG/mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2716485 | SITagliptin 25 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2716485 | SITagliptin 25 MG/mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2716485 | SITagliptin 25 MG/mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2716486 | Brynovin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2716487 | sitagliptin 25 MG/ML [Brynovin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2716487 | sitagliptin 25 MG/ML [Brynovin] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2716488 | Brynovin Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2716489 | Brynovin Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2716490 | sitagliptin Oral Solution [Brynovin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2716490 | sitagliptin Oral Solution [Brynovin] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2716491 | Brynovin 25 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2716491 | Brynovin 25 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2716491 | Brynovin 25 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2716491 | Brynovin 25 MG/mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2716491 | Brynovin 25 MG/mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2716497 | Zelsuvmi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2716498 | berdazimer 0.103 MG/MG [Zelsuvmi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2716499 | Zelsuvmi Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2716500 | berdazimer Topical Gel [Zelsuvmi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2716549 | hydrocortisone Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2716550 | hydrocortisone 1 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2716550 | hydrocortisone 1 MG/mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2716551 | Khindivi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2716552 | hydrocortisone 1 MG/ML [Khindivi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2716553 | Khindivi Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2716554 | Khindivi Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2716555 | hydrocortisone Oral Solution [Khindivi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2716556 | Khindivi 1 MG/mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2716556 | Khindivi 1 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2716556 | Khindivi 1 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2716557 | deuruxolitinib phosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2716558 | deuruxolitinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2716559 | deuruxolitinib 8 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2716560 | deuruxolitinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2716561 | deuruxolitinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2716562 | deuruxolitinib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2716563 | deuruxolitinib 8 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2716563 | deuruxolitinib 8 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2716564 | Leqselvi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2716565 | deuruxolitinib 8 MG [Leqselvi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2716566 | Leqselvi Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2716567 | Leqselvi Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2716568 | deuruxolitinib Oral Tablet [Leqselvi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2716569 | LEQSELVI 8 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2716569 | LEQSELVI 8 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2716569 | LEQSELVI 8 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2716571 | Meleya 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 2716571 | Meleya 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2716571 | Meleya 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2716574 | collagen alpha-1(VII) chain | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2716578 | capsaicin 0.05 % / menthol 2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2716578 | capsaicin 0.05 % / menthol 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2716578 | capsaicin 0.05 % / menthol 2 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2716690 | Ampromax | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 2716691 | amprolium 96 MG/ML [Ampromax] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2716692 | Ampromax Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2716693 | Ampromax Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2716694 | amprolium Oral Solution [Ampromax] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2716695 | Ampromax 9.6 % Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2716695 | Ampromax 9.6 % Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2716695 | Ampromax 9.6 % Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2716695 | Ampromax 9.6 % Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2716696 | spesolimab-sbzo 300 MG in 2 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2716696 | spesolimab-sbzo 300 MG in 2 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2716696 | spesolimab-sbzo 300 MG in 2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2716697 | Spevigo 300 MG in 2 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2716697 | Spevigo 300 MG in 2 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2716697 | Spevigo 300 MG in 2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2716698 | dextromethorphan HBr 15 MG / pyrilamine maleate 15 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2716698 | dextromethorphan HBr 15 MG / pyrilamine maleate 15 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2716698 | dextromethorphan HBr 15 MG / pyrilamine maleate 15 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2716699 | Jaythari | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2716700 | deflazacort 18 MG [Jaythari] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2716701 | Jaythari Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2716702 | Jaythari Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2716703 | deflazacort Oral Tablet [Jaythari] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2716704 | JAYTHARI 18 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2716704 | JAYTHARI 18 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2716704 | JAYTHARI 18 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2716705 | deflazacort 30 MG [Jaythari] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2716706 | JAYTHARI 30 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2716706 | JAYTHARI 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2716706 | JAYTHARI 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2716707 | deflazacort 36 MG [Jaythari] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2716708 | JAYTHARI 36 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2716708 | JAYTHARI 36 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2716708 | JAYTHARI 36 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2716709 | deflazacort 6 MG [Jaythari] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2716710 | JAYTHARI 6 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2716710 | JAYTHARI 6 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2716710 | JAYTHARI 6 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2716711 | simethicone 500 MG [Gas-X] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2716712 | Gas-X 500 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2716712 | Gas-X 500 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2716712 | Gas-X 500 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2716713 | calcium citrate 200 MG / vitamin D3 250 UNT Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2716713 | calcium citrate 200 MG / vitamin D3 250 UNT Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2716713 | calcium citrate 200 MG / vitamin D3 250 UNT Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2716714 | bacitracin / lidocaine / polymyxin B Topical Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2716717 | bacitracin zinc 500 UNT / lidocaine 40 MG / polymyxin B sulfate 10,000 UNT in GM Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2716717 | bacitracin zinc 500 UNT / lidocaine 40 MG / polymyxin B sulfate 10,000 UNT in GM Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2716717 | bacitracin zinc 500 UNT / lidocaine 40 MG / polymyxin B sulfate 10,000 UNT in GM Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2716718 | Giarcidia | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 2716719 | praziquantel 50 MG/ML [Giarcidia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2716720 | Giarcidia Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2716721 | Giarcidia Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2716722 | praziquantel Oral Suspension [Giarcidia] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2716723 | GiarCidia 50 MG/mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2716723 | GiarCidia 50 MG/mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2716723 | GiarCidia 50 MG/mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2716724 | fenbendazole 42.9 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2716725 | pyrantel 28.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2716726 | fenbendazole / pyrantel | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
RxCUI: 2716727 | fenbendazole / pyrantel Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 2716728 | fenbendazole / pyrantel Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 2716729 | fenbendazole / pyrantel Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2716730 | fenbendazole 42.9 MG / pyrantel 28.5 MG in 1 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2716730 | fenbendazole 42.9 MG / pyrantel 28.5 MG in 1 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2716730 | fenbendazole 42.9 MG / pyrantel 28.5 MG in 1 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2716731 | GiarcidiaZap-Wormer | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 2716732 | fenbendazole 42.9 MG/ML / pyrantel 28.5 MG/ML [GiarcidiaZap-Wormer] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2716733 | GiarcidiaZap-Wormer Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2716734 | GiarcidiaZap-Wormer Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2716735 | fenbendazole / pyrantel Oral Suspension [GiarcidiaZap-Wormer] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2716736 | GiarCidia Zap-Wormer (fenbendazole 42.86 MG / pyrantel 28.54 MG in 1 mL) Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2716736 | GiarCidia Zap-Wormer (fenbendazole 42.86 MG / pyrantel 28.54 MG in 1 mL) Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2716736 | GiarCidia Zap-Wormer (fenbendazole 42.86 MG / pyrantel 28.54 MG in 1 mL) Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2716737 | Bactine Antibiotic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 2716738 | bacitracin zinc 0.5 UNT/MG / lidocaine 0.04 MG/MG / polymyxin B sulfate 10 UNT/MG [Bactine Antibiotic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2716739 | Bactine Antibiotic Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2716740 | bacitracin / lidocaine / polymyxin B Topical Ointment [Bactine Antibiotic] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2716742 | Bactine Max Antibiotic (bacitracin zinc 500 UNT / lidocaine 40 MG / polymyxin B sulfate 10,000 UNT) per GM Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2716742 | Bactine Max Antibiotic (bacitracin zinc 500 UNT / lidocaine 40 MG / polymyxin B sulfate 10,000 UNT) per GM Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2716742 | Bactine Max Antibiotic (bacitracin zinc 500 UNT / lidocaine 40 MG / polymyxin B sulfate 10,000 UNT) per GM Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2716797 | baloxavir marboxil 30 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2716798 | baloxavir marboxil 30 MG Granules for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2716798 | baloxavir marboxil 30 MG Granules for Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2716799 | baloxavir marboxil 30 MG [Xofluza] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2716800 | Xofluza 30 MG Granules for Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2716800 | Xofluza 30 MG Granules for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2716800 | Xofluza 30 MG Granules for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2716801 | acoltremon | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2716802 | clesrovimab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2716803 | clesrovimab-cfor | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2716804 | clesrovimab-cfor 150 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2716805 | clesrovimab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2716806 | clesrovimab Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2716809 | clesrovimab-cfor 105 MG in 0.7 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2716809 | clesrovimab-cfor 105 MG in 0.7 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2716809 | clesrovimab-cfor 105 MG in 0.7 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2716810 | clesrovimab-cfor 150 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2716811 | Enflonsia | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2716812 | clesrovimab-cfor 150 MG/ML [Enflonsia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2716813 | Enflonsia Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2716814 | clesrovimab Prefilled Syringe [Enflonsia] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2716816 | ENFLONSIA 105 MG in 0.7 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2716816 | ENFLONSIA 105 MG in 0.7 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2716816 | ENFLONSIA 105 MG in 0.7 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2716816 | ENFLONSIA 105 MG in 0.7 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2716817 | clesrovimab-cfor 150 MG/ML Prefilled Syringe [Enflonsia] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2716817 | clesrovimab-cfor 150 MG/ML Prefilled Syringe [Enflonsia] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2716818 | acoltremon 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2716819 | acoltremon Ophthalmic Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2716820 | acoltremon Ophthalmic Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2716821 | acoltremon 0.003 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2716821 | acoltremon 0.003 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2716821 | acoltremon 0.003 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2716822 | Tryptyr | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2716823 | acoltremon 0.03 MG/ML [Tryptyr] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2716824 | Tryptyr Ophthalmic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2716825 | acoltremon Ophthalmic Solution [Tryptyr] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2716826 | TRYPTYR 0.003 % Ophthalmic Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2716826 | TRYPTYR 0.003 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2716826 | TRYPTYR 0.003 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2716826 | TRYPTYR 0.003 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2716827 | dibasic potassium phosphate 11.8 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2716828 | monobasic potassium phosphate 11.2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2716829 | potassium phosphates (phosphorus 15 MMOL / potassium 22 MEQ) in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2716829 | potassium phosphates (phosphorus 15 MMOL / potassium 22 MEQ) in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2716829 | potassium phosphates (phosphorus 15 MMOL / potassium 22 MEQ) in 100 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2716829 | potassium phosphates (phosphorus 15 MMOL / potassium 22 MEQ) in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2716829 | potassium phosphates (phosphorus 15 MMOL / potassium 22 MEQ) in 100 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2716830 | dibasic K+ phosphate 11.8 MG/ML / monobasic K+ phosphate 11.2 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2716830 | dibasic K+ phosphate 11.8 MG/ML / monobasic K+ phosphate 11.2 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2716830 | dibasic K+ phosphate 11.8 MG/ML / monobasic K+ phosphate 11.2 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 27169 | leflunomide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 27169 | leflunomide | Designated preferred name (PT) | YES | |
RxCUI: 27169 | leflunomide | Full form of descriptor (FN) | YES | |
RxCUI: 27169 | leflunomide | Designated preferred name (PT) | YES | |
RxCUI: 27169 | leflunomide | Full form of descriptor (FN) | YES | |
RxCUI: 2716916 | progesterone 213 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2716917 | progesterone Topical Oil | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2716918 | progesterone 21.3 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2716918 | progesterone 21.3 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2716918 | progesterone 21.3 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2716919 | taletrectinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2716920 | taletrectinib adipate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2716921 | taletrectinib 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2716922 | taletrectinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2716923 | taletrectinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2716924 | taletrectinib Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2716925 | taletrectinib 200 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2716925 | taletrectinib 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2716925 | taletrectinib 200 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2716926 | Ibtrozi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2716927 | taletrectinib 200 MG [Ibtrozi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2716928 | Ibtrozi Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2716929 | Ibtrozi Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2716930 | taletrectinib Oral Capsule [Ibtrozi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2716931 | IBTROZI 200 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2716931 | IBTROZI 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2716931 | IBTROZI 200 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2716932 | sodium bicarbonate 16500 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2716933 | sodium chloride 49500 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2716934 | sodium bicarbonate 16500 MG / sodium chloride 49500 MG Powder for Nasal Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2716934 | sodium bicarbonate 16500 MG / sodium chloride 49500 MG Powder for Nasal Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2716934 | sodium bicarbonate 16500 MG / sodium chloride 49500 MG Powder for Nasal Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2716983 | chaste tree fruit oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2717063 | ustekinumab-srlf | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2717064 | ustekinumab-srlf 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2717067 | ustekinumab-srlf 130 MG in 26 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2717067 | ustekinumab-srlf 130 MG in 26 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2717067 | ustekinumab-srlf 130 MG in 26 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2717068 | ustekinumab-srlf 5 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2717068 | ustekinumab-srlf 5 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2717069 | Imuldosa | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2717070 | ustekinumab-srlf 5 MG/ML [Imuldosa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2717071 | Imuldosa Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2717072 | ustekinumab Injection [Imuldosa] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2717074 | IMULDOSA 130 MG in 26 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2717074 | IMULDOSA 130 MG in 26 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2717074 | IMULDOSA 130 MG in 26 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2717075 | IMULDOSA 5 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2717075 | IMULDOSA 5 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2717075 | IMULDOSA 5 MG/ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2717076 | ustekinumab-srlf 90 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2717078 | ustekinumab-srlf 45 MG in 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2717078 | ustekinumab-srlf 45 MG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2717078 | ustekinumab-srlf 45 MG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2717079 | ustekinumab-srlf 90 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2717079 | ustekinumab-srlf 90 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2717080 | ustekinumab-srlf 90 MG/ML [Imuldosa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2717081 | ustekinumab Prefilled Syringe [Imuldosa] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2717083 | IMULDOSA 45 MG in 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2717083 | IMULDOSA 45 MG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2717083 | IMULDOSA 45 MG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2717084 | IMULDOSA 90 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2717084 | IMULDOSA 90 MG/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2717084 | IMULDOSA 90 MG/ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2717085 | ustekinumab-srlf 90 MG in 1 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2717085 | ustekinumab-srlf 90 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2717085 | ustekinumab-srlf 90 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2717086 | IMULDOSA 90 MG in 1 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2717086 | IMULDOSA 90 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2717086 | IMULDOSA 90 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 27171 | Hyaluronate lyase | Designated preferred name (PT) | NO | |
RxCUI: 27171 | Hyaluronate lyase | Full form of descriptor (FN) | NO | |
RxCUI: 2717168 | garadacimab-gxii | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2717169 | garadacimab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2717170 | garadacimab-gxii 167 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2717171 | garadacimab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2717172 | garadacimab Auto-Injector | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2717175 | garadacimab-gxii 200 MG in 1.2 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2717175 | garadacimab-gxii 200 MG in 1.2 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2717175 | garadacimab-gxii 200 MG in 1.2 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2717176 | garadacimab-gxii 167 MG/ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2717176 | garadacimab-gxii 167 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2717177 | Andembry | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2717178 | garadacimab-gxii 167 MG/ML [Andembry] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2717179 | Andembry Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2717180 | garadacimab Auto-Injector [Andembry] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2717182 | ANDEMBRY 200 MG in 1.2 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2717182 | ANDEMBRY 200 MG in 1.2 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2717182 | ANDEMBRY 200 MG in 1.2 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2717183 | ANDEMBRY 167 MG/ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2717183 | ANDEMBRY 167 MG/ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2717183 | ANDEMBRY 167 MG/ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2717184 | piroctone olamine / salicylic acid Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 2717185 | piroctone olamine / salicylic acid Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2717186 | piroctone olamine 0.5 % / salicylic acid 1.5 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2717186 | piroctone olamine 0.5 % / salicylic acid 1.5 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2717186 | piroctone olamine 0.5 % / salicylic acid 1.5 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2717187 | toltrazuril 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2717188 | toltrazuril Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 2717189 | toltrazuril Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 2717190 | toltrazuril Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2717191 | totrazuril 5 % Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2717191 | totrazuril 5 % Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2717191 | totrazuril 5 % Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2717192 | Yeztugo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2717193 | lenacapavir 300 MG [Yeztugo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2717194 | Yeztugo Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2717195 | Yeztugo Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2717196 | lenacapavir Oral Tablet [Yeztugo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2717197 | Yeztugo 300 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2717197 | Yeztugo 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2717197 | Yeztugo 300 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2717198 | lenacapavir 309 MG/ML [Yeztugo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2717199 | Yeztugo Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2717200 | lenacapavir Injection [Yeztugo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2717201 | Yeztugo 463.5 MG in 1.5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2717201 | Yeztugo 463.5 MG in 1.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2717201 | Yeztugo 463.5 MG in 1.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2717202 | Yeztugo 309 MG/ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2717202 | Yeztugo 309 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2717202 | Yeztugo 309 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2717203 | Yeztugo 927 MG 2-Vial Kit | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 2717203 | Yeztugo 927 MG 2-Vial Kit | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2717203 | Yeztugo 927 MG 2-Vial Kit | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2717261 | hexamidine diisethionate 0.1 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2717261 | hexamidine diisethionate 0.1 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2717261 | hexamidine diisethionate 0.1 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2717262 | Habitrol Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2717263 | nicotine Chewing Gum [Habitrol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2717264 | Habitrol 4 MG Chewing Gum | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2717264 | Habitrol 4 MG Chewing Gum | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2717264 | Habitrol 4 MG Chewing Gum | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2717265 | sirolimus 2.4 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2717266 | sirolimus Delayed Release Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2717267 | sirolimus 2.4 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2717267 | sirolimus 2.4 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2717268 | Felycin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 2717269 | sirolimus 2.4 MG [Felycin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2717270 | Felycin Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2717271 | Felycin Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2717272 | sirolimus Delayed Release Oral Tablet [Felycin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2717273 | felycin 2.4 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2717273 | felycin 2.4 MG Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2717273 | felycin 2.4 MG Delayed Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2717274 | sirolimus 1.2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2717275 | sirolimus 1.2 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2717275 | sirolimus 1.2 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2717276 | sirolimus 1.2 MG [Felycin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2717277 | felycin 1.2 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2717277 | felycin 1.2 MG Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2717277 | felycin 1.2 MG Delayed Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2717278 | sirolimus 0.4 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2717279 | sirolimus 0.4 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2717279 | sirolimus 0.4 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2717280 | sirolimus 0.4 MG [Felycin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2717281 | felycin 0.4 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2717281 | felycin 0.4 MG Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2717281 | felycin 0.4 MG Delayed Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2717282 | Lidoguard Pain Relief | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2717283 | lidocaine 0.04 MG/MG [Lidoguard Pain Relief] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2717284 | Lidoguard Pain Relief Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2717285 | lidocaine Medicated Patch [Lidoguard Pain Relief] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2717286 | LidoGuard 4 % Medicated Patch | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2717286 | LidoGuard 4 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2717286 | LidoGuard 4 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2717316 | Xifyrm | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2717317 | meloxicam 30 MG/ML [Xifyrm] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2717318 | Xifyrm Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2717319 | meloxicam Injection [Xifyrm] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2717320 | Xifyrm 30 MG in 1 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2717320 | Xifyrm 30 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2717320 | Xifyrm 30 MG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2717320 | Xifyrm 30 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2717321 | meloxicam 30 MG/ML Injection [Xifyrm] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2717321 | meloxicam 30 MG/ML Injection [Xifyrm] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 271743 | piperazine hexahydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 271769 | Norcholestenol iodomethyl (131-I) | Designated preferred name (PT) | NO | |
RxCUI: 271769 | Norcholestenol iodomethyl (131-I) | Full form of descriptor (FN) | NO | |
RxCUI: 2718 | Collagen type III | Designated preferred name (PT) | NO | |
RxCUI: 2718 | Collagen type III | Full form of descriptor (FN) | NO | |
RxCUI: 27184 | Hydrargaphen | Designated preferred name (PT) | NO | |
RxCUI: 27184 | Hydrargaphen | Full form of descriptor (FN) | NO | |
RxCUI: 27184 | Hydrargaphen | Designated preferred name (PT) | NO | |
RxCUI: 27184 | Hydrargaphen | Full form of descriptor (FN) | NO | |
RxCUI: 27185 | Hydrastine | Designated preferred name (PT) | NO | |
RxCUI: 27185 | Hydrastine | Full form of descriptor (FN) | NO | |
RxCUI: 2719 | Collagen type IV | Designated preferred name (PT) | NO | |
RxCUI: 2719 | Collagen type IV | Full form of descriptor (FN) | NO | |
RxCUI: 27196 | Hydrocortisone butyrate propionate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 27196 | Hydrocortisone butyrate propionate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 27196 | Hydrocortisone butyrate propionate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 27196 | Hydrocortisone butyrate propionate | Designated preferred name (PT) | YES | |
RxCUI: 27196 | Hydrocortisone butyrate propionate | Full form of descriptor (FN) | YES | |
RxCUI: 27197 | hydrocortisone acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 27197 | hydrocortisone acetate | Designated preferred name (PT) | YES | |
RxCUI: 27197 | hydrocortisone acetate | Full form of descriptor (FN) | YES | |
RxCUI: 27199 | hydrocortisone valerate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 27199 | hydrocortisone valerate | Designated preferred name (PT) | YES | |
RxCUI: 27199 | hydrocortisone valerate | Full form of descriptor (FN) | YES |